- 全部删除
- 您的购物车当前为空
Tyrosinase-IN-13 (compound 3c)为Flurbiprofen的衍生物,具有非竞争性酪氨酸酶抑制活性(IC50=68 μM;Ki=36.3 μM),并对肝细胞癌(HepG2)、结直肠癌(HT-29)及黑色素瘤(B16F10)细胞表现出细胞毒性。
Tyrosinase-IN-13 (compound 3c)为Flurbiprofen的衍生物,具有非竞争性酪氨酸酶抑制活性(IC50=68 μM;Ki=36.3 μM),并对肝细胞癌(HepG2)、结直肠癌(HT-29)及黑色素瘤(B16F10)细胞表现出细胞毒性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 待询 | 待询 | |
50 mg | 待询 | 待询 |
Tyrosinase-IN-13 相关产品
产品描述 | Tyrosinase-IN-13 (compound 3c), stemming from Flurbiprofen, acts as a potent non-competitive inhibitor of tyrosinase, exhibiting IC50 and Ki values of 68 μM and 36.3 μM respectively. This compound demonstrates cytotoxicity against several cancer cell lines, including hepatocellular carcinoma (HepG2), colorectal cancer (HT-29), and melanoma (B16F10) [1]. |
分子量 | 452.93 |
分子式 | C23H18ClFN4OS |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容